Patrick H. Maxwell
Impact in
- Cancer Research top 0.01%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 0.05%
- Mitochondrial Function and Pathology
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Angiogenesis and VEGF in Cancer
- Ubiquitin and proteasome pathways
Papers in
- Cancer Research 125
- Cancer, Hypoxia, and Metabolism 122
-
- Mitochondrial Function and Pathology 17
- Renal and related cancers 15
- Epigenetics and DNA Methylation 14
- Co-authors
- Peter J. Ratcliffe (53 shared papers)Christopher W. Pugh (39 shared papers)Michael S. Wiesener (17 shared papers)David R. Mole (6 shared papers)Adrian L. Harris (13 shared papers)Charles C. Wykoff (6 shared papers)Eamonn R. Maher (7 shared papers)Panu Jaakkola (3 shared papers)
- Journals
- Kidney International (11 papers)Journal of the American Society of Nephrology (9 papers)Blood (8 papers)PLoS ONE (6 papers)Journal of Clinical Investigation (6 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Patrick H. Maxwell
212 papers receiving 34.1k citations
Patrick H. Maxwell's Hit Papers
Peers
Comparison fields: 5 of 177
- Cancer Research 21.6k
- Molecular Biology 20.1k
- Hematology 2.6k
- Biochemistry 1.6k
- Genetics 2.1k
Countries citing papers authored by Patrick H. Maxwell
This map shows the geographic impact of Patrick H. Maxwell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick H. Maxwell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick H. Maxwell more than expected).
Fields of papers citing papers by Patrick H. Maxwell
This network shows the impact of papers produced by Patrick H. Maxwell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick H. Maxwell. The network helps show where Patrick H. Maxwell may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick H. Maxwell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 213 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation Hit paper breakdown → | 2001 | 4523 |
| 2 | The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Hit paper breakdown → | 1999 | 4162 |
| 3 | C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation Hit paper breakdown → | 2001 | 2746 |
| 4 | Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis Hit paper breakdown → | 1998 | 2119 |
| 5 | Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Hit paper breakdown → | 2000 | 1092 |
| 6 | The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages Hit paper breakdown → | 2000 | 1078 |
| 7 | Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth Hit paper breakdown → | 1997 | 919 |
| 8 | Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein Hit paper breakdown → | 2000 | 893 |
| 9 | Independent function of two destruction domains in hypoxia-inducible factor-α chains activated by prolyl hydroxylation Hit paper breakdown → | 2001 | 856 |
| 10 | Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma Hit paper breakdown → | 2005 | 760 |
| 11 | Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL Hit paper breakdown → | 2002 | 611 |
| 12 | Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs Hit paper breakdown → | 2002 | 582 |
| 13 | Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α Hit paper breakdown → | 1998 | 539 |
| 14 | Expression of Hypoxia-Inducible Factor-1α and -2α in Hypoxic and Ischemic Rat Kidneys Hit paper breakdown → | 2002 | 480 |
| 15 | HIF activation identifies early lesions in VHL kidneys Hit paper breakdown → | 2002 | 398 |
| 16 | 2002 | 382 | |
| 17 | 2001 | 339 | |
| 18 | 1998 | 305 | |
| 19 | Identification of the renal erythropoietin-producing cells using transgenic mice Hit paper breakdown → | 1993 | 301 |
| 20 | 2006 | 282 |
About Patrick H. Maxwell
Patrick H. Maxwell is a scholar working on Cancer Research, Molecular Biology, Genetics, Physiology and Pulmonary and Respiratory Medicine, having authored 213 papers that have together received 34.6k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (122 papers), High Altitude and Hypoxia (30 papers), Erythropoietin and Anemia Treatment (22 papers), Mitochondrial Function and Pathology (17 papers), Renal and related cancers (15 papers), Adipose Tissue and Metabolism (15 papers), Renal Diseases and Glomerulopathies (14 papers) and Epigenetics and DNA Methylation (14 papers). The work is most often cited by research in Cancer Research (21.6k citations), Molecular Biology (20.1k citations), Hematology (2.6k citations), Biochemistry (1.6k citations) and Genetics (2.1k citations). Patrick H. Maxwell has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Peter J. Ratcliffe, Christopher W. Pugh, Michael S. Wiesener, David R. Mole, Adrian L. Harris, Charles C. Wykoff, Eamonn R. Maher, Panu Jaakkola, Christopher J. Schofield and Michael Wilson. Their work appears in journals such as Kidney International, Journal of the American Society of Nephrology, Blood, PLoS ONE and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.